XIAP antisense therapy with AEG 35156 in acute myeloid leukemia

Author： Katragadda Lakshmikanth Carter Bing Z Borthakur Gautam

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.22, Iss.5, 2013-06, pp. : 663-670

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Therapy for Acute Myeloid Leukemia

By Kohrt Holbrook E. Coutre Steven E.

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 1003-1016

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

New Developments of Differentiation Therapy of Acute Myeloid Leukemia

Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol. 14, Iss. 2, 2017-04 ,pp. : 86-105

Bentham Science Publishers

Access to resources Recommend Favorite

Development of personalized molecular therapy for acute myeloid leukemia

Current Pharmaceutical Biotechnology, Vol. 17, Iss. 1, 2016-01 ,pp. : 20-29

Bentham Science Publishers

Access to resources Recommend Favorite

Acute Myeloid Leukemia

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 6, Iss. 10, 2008-11 ,pp. : 962-962

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Pharmacogenomics in acute myeloid leukemia

By Roumier Christophe Cheok Meyling H

Pharmacogenomics, Vol. 10, Iss. 11, 2009-11 ,pp. : 1839-1851

Future Medicine

Access to resources Recommend Favorite